142 related articles for article (PubMed ID: 37499886)
1. Derlin-1 ameliorates nonalcoholic hepatic steatosis by promoting ubiquitylation and degradation of FABP1.
You H; Wen X; Wang X; Zhu C; Chen H; Bu L; Zhang J; Qu S
Free Radic Biol Med; 2023 Oct; 207():260-271. PubMed ID: 37499886
[TBL] [Abstract][Full Text] [Related]
2. Long-term exercise prevents hepatic steatosis: a novel role of FABP1 in regulation of autophagy-lysosomal machinery.
Pi H; Liu M; Xi Y; Chen M; Tian L; Xie J; Chen M; Wang Z; Yang M; Yu Z; Zhou Z; Gao F
FASEB J; 2019 Nov; 33(11):11870-11883. PubMed ID: 31366243
[TBL] [Abstract][Full Text] [Related]
3. Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice.
Li K; Zhang K; Wang H; Wu Y; Chen N; Chen J; Qiu C; Cai P; Li M; Liang X; Su D
Metabolism; 2021 Jan; 114():154349. PubMed ID: 32888949
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein.
Wu YL; Peng XE; Zhu YB; Yan XL; Chen WN; Lin X
J Virol; 2016 Feb; 90(4):1729-40. PubMed ID: 26637457
[TBL] [Abstract][Full Text] [Related]
5. Derlin-1 promotes ubiquitylation and degradation of the epithelial Na
You H; Ge Y; Zhang J; Cao Y; Xing J; Su D; Huang Y; Li M; Qu S; Sun F; Liang X
J Cell Sci; 2017 Mar; 130(6):1027-1036. PubMed ID: 28137758
[TBL] [Abstract][Full Text] [Related]
6. Multiple MicroRNAs Ameliorate Hepatocyte Steatosis and Injury by Suppressing FABP1 Expression.
Wu YL; Zhu YB; Huang RD; Peng XE; Lin X
Cell Physiol Biochem; 2017; 44(6):2243-2255. PubMed ID: 29258109
[TBL] [Abstract][Full Text] [Related]
7. The DEAD-box helicase DDX3x ameliorates non-alcoholic fatty liver disease via mTORC1 signalling pathway.
Liu P; Zhang Y; Tang C; Cen L; Chen Y; Li S; Chen X; Yu M; Zhang J; Zhang X; Zeng H; Xu C; Yu C
Liver Int; 2022 Aug; 42(8):1793-1802. PubMed ID: 35460172
[TBL] [Abstract][Full Text] [Related]
8. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease.
Guzmán C; Benet M; Pisonero-Vaquero S; Moya M; García-Mediavilla MV; Martínez-Chantar ML; González-Gallego J; Castell JV; Sánchez-Campos S; Jover R
Biochim Biophys Acta; 2013 Apr; 1831(4):803-18. PubMed ID: 23318274
[TBL] [Abstract][Full Text] [Related]
9. F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit.
Liu Z; Chen NY; Zhang Z; Zhou S; Hu SY
World J Gastroenterol; 2023 Jul; 29(28):4433-4450. PubMed ID: 37576703
[TBL] [Abstract][Full Text] [Related]
10. Derlin-1 promotes diet-induced non-alcoholic fatty liver disease via increasing RIPK3-mediated necroptosis.
Wang T; Wang D; Kuang G; Gong X; Zhang L; Wan J; Li K
Free Radic Biol Med; 2024 May; 217():29-47. PubMed ID: 38522486
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Yin X; Liu Z; Wang J
Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
[TBL] [Abstract][Full Text] [Related]
12. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
[TBL] [Abstract][Full Text] [Related]
13. The critical role of BTRC in hepatic steatosis as an ATGL E3 ligase.
Qi W; Fang Z; Luo C; Hong H; Long Y; Dai Z; Liu J; Zeng Y; Zhou T; Xia Y; Yang X; Gao G
J Mol Cell Biol; 2024 Apr; 15(10):. PubMed ID: 37873692
[TBL] [Abstract][Full Text] [Related]
14. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
Hong Y; Choi SI; Hong E; Kim GH
J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
[TBL] [Abstract][Full Text] [Related]
15. The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1.
Yang Q; Chen X; Zhang Y; Hu S; Hu F; Huang Y; Ma T; Hu H; Tian H; Tian S; Ji YX; She ZG; Zhang P; Zhang XJ; Hu Y; Yang H; Yuan Y; Li H
Hepatology; 2021 Dec; 74(6):3018-3036. PubMed ID: 34272738
[TBL] [Abstract][Full Text] [Related]
16. Ablating both Fabp1 and Scp2/Scpx (TKO) induces hepatic phospholipid and cholesterol accumulation in high fat-fed mice.
Milligan S; Martin GG; Landrock D; McIntosh AL; Mackie JT; Schroeder F; Kier AB
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Mar; 1863(3):323-338. PubMed ID: 29307784
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
[TBL] [Abstract][Full Text] [Related]
18. TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4α stability.
Xiao MC; Jiang N; Chen LL; Liu F; Liu SQ; Ding CH; Wu SH; Wang KQ; Luo YY; Peng Y; Yan FZ; Zhang X; Qian H; Xie WF
J Hepatol; 2024 May; 80(5):778-791. PubMed ID: 38237865
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.
Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J
Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567
[TBL] [Abstract][Full Text] [Related]
20. Human Liver Fatty Acid Binding Protein-1 T94A Variant, Nonalcohol Fatty Liver Disease, and Hepatic Endocannabinoid System.
Martin GG; Landrock D; Dangott LJ; McIntosh AL; Kier AB; Schroeder F
Lipids; 2018 Jan; 53(1):27-40. PubMed ID: 29488637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
